Autonomic dysfunction in Parkinson's disease

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
G MicieliA Cavallini

Abstract

Autonomic dysfunction in patients with Parkinson's disease (PD) has been recognized since the original description by James Parkinson in 1817. Autonomic failure can be the clinical presentation of other diseases like pure autonomic failure (PAF) and multiple system atrophy (MSA). Both the central and peripheral autonomic nervous systems can be affected in PD. Rajput and Rozdilsky described cell loss and Lewy bodies within the sympathetic ganglia and antibodies to sympathetic neurons have been detected in PD patients. Lewy bodies can be seen in autonomic regulatory regions, including the hypothalamus, sympathetic (intermediolateral nucleus of the thoracic cord and sympathetic ganglia), and parasympathetic system (dorsal, vagal, and sacral parasympathetic nuclei). Lewy bodies were also found in the adrenal medulla and in the neural plexi innervating the gut, heart and pelvis. Symptoms of dysautonomia are variable, and include cardiovascular symptoms, gastrointestinal, urogenital, sudomotor and thermoregulatory dysfunction, pupillary abnormalities and sleep and respiratory disorders. They may represent a useful tool in the differential diagnosis of "atypical" or "complicated" parkinsonisms.

Citations

May 6, 2010·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Axel BuobM Böhm
May 13, 2011·Journal of Neurology·Tjalf ZiemssenBirgit Herting
Sep 15, 2004·Cell and Tissue Research·Thomas Klockgether
Feb 13, 2008·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Norio HoriGen Sobue
May 18, 2010·Sleep & Breathing = Schlaf & Atmung·Wattanachai ChotinaiwattarakulRoger L Albin
May 3, 2007·Journal of Palliative Medicine·Lauren B ElmanLeo McCluskey
Jan 18, 2013·Parkinson's Disease·Todd J Swick
Feb 1, 2007·Neuropsychiatric Disease and Treatment·Clelia PellicanoFrancesco E Pontieri
Apr 16, 2009·Internal Medicine·Yoshihide Sehara
Nov 2, 2013·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Christopher GibbonsThomas Chelimsky
Oct 27, 2010·Parkinson's Disease·K SlackJ M Henderson
Oct 27, 2007·Neuropathology and Applied Neurobiology·C H HawkesH Braak
Aug 18, 2012·La Presse médicale·Jean-Michel SenardAtul Pathak
Nov 27, 2004·Mechanisms of Ageing and Development·M Jill Saffrey
Mar 1, 2017·Methods of Information in Medicine·Sergio Albiol-PérezJosé-Antonio Lozano-Quilis
Jan 19, 2016·Medical Engineering & Physics·Kazuhiro OgaiTetsu Nemoto
May 10, 2017·The International Journal of Neuroscience·Arina MadanPinky Agarwal
Nov 13, 2004·Journal of Clinical Psychopharmacology·Jong-Hoon KimYong Sik Kim
Feb 12, 2017·Neuroscience and Biobehavioral Reviews·Ryan SmithRichard D Lane
Jan 9, 2017·La Presse médicale·Jean-Philippe AzulayAlexandre Eusebio
Dec 29, 2016·Acta neurologica Belgica·Svetlana TomicSanja Misevic
Dec 25, 2010·Therapeutic Advances in Neurological Disorders·Tjalf Ziemssen, Heinz Reichmann
Mar 18, 2017·Journal of Biomechanical Engineering·Leszek PstrasFederico Bellavere
Nov 3, 2015·Chinese Medical Journal·Li-Mei Zhang, Xu-Ping Zhang
Jun 30, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Jenny Jamnadas-KhodaSubbakrishna K Dodaballapur
Aug 19, 2009·Annals of the New York Academy of Sciences·Christopher H HawkesHeiko Braak
Jul 12, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Nico J DiederichMarc Schlesser
Mar 21, 2006·The Neurologist·Basil Ridha, Keith A Josephs
Sep 15, 2018·Behavioural Pharmacology·Adjia HamadjidaPhilippe Huot
Nov 7, 2018·Oxford Medical Case Reports·Hiroshi KataokaKazuma Sugie
Mar 13, 2020·Journal of Neurology·Dagmar N van DeursenChris Vriend
Jan 12, 2020·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Hsiu-Ling ChenWei-Che Lin
Mar 7, 2017·Frontiers in Neurology·Giuseppe LoddoFederica Provini
Feb 16, 2016·Oral Diseases·J-Lc MougeotFkb Mougeot
Sep 12, 2018·Acta Neuropathologica Communications·Isabel Ortuño-LizaránNicolás Cuenca
Sep 25, 2012·Acta Neurologica Scandinavica·B MüllerUNKNOWN ParkWest study group
Jun 27, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Silvia Rios RomenetsRonald B Postuma
Mar 10, 2016·Proteomics·Nukala Sarath BabuMohammed M Idris
Apr 24, 2020·Frontiers in Pharmacology·Elena Paredes-RodriguezCristina Miguelez
Oct 13, 2015·World Journal of Gastroenterology : WJG·Agata Mulak, Bruno Bonaz
Aug 28, 2020·Brain Sciences·Patrick S HosfordShahriar SheikhBahaei
Sep 13, 2017·Frontiers in Neuroscience·Tumul ChowdhuryRonald B Cappellani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Bioenergetics and Biomembranes
George H Sack
Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie
M Turgut
Parkinsonism & Related Disorders
H Takahashi, K Wakabayashi
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme
I BanegasI Prieto
© 2022 Meta ULC. All rights reserved